Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.050
0.00 (0.00%)
At close: Jul 16, 2026

HRGN Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.890.70.430.1--
Revenue Growth
111.72%63.72%317.48%---
Gross Profit
0.070.060.160.08--
Operating Income
-6.85-6.92-7.23-8.99-6.07-8.64
Net Income
-6.81-6.87-7.73-9.02-6.25-7.98
Earnings Per Share
-0.40-0.42-0.52-0.67-0.55-0.79
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.421.352.490.431.261.47
Total Debt
0.170.20.290.050.150.17
Net Cash (Debt)
0.251.152.190.381.111.3
Net Cash Growth
-83.10%-47.40%470.83%-65.53%-14.18%195.00%
Net Cash Per Share
0.010.070.150.030.100.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.01-3.83-4.85-6.94-5.11-2.63
Capital Expenditures
----0.01-0.01-
Free Cash Flow
-4.01-3.83-4.85-6.95-5.11-2.63
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.46%8.24%37.21%76.70%--
Operating Margin
-774.12%-982.24%-1680.46%-8728.15%--
Pretax Margin
-769.60%-975.71%-1798.14%-8684.47%--
Profit Margin
-769.61%-975.71%-1798.14%-8759.22%--
FCF Margin
-452.77%-543.75%-1128.37%-6747.57%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
20.8644.87110.32675.70--